Gilead Sciences, Inc.
Gilead Sciences, Inc.
GILD
Valuace
35
Růst
40
Zdraví
80
Cena
$ 117.95
Dnes
+3.65 (3.01%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
146.4B
Obrat
29B
Zisk
9B
Aktiva
59B
Dluh
25B
ROE
0%
ROA
0%
PE
20
PS
6
Cena 1R
92-129
⌀ Cena
114.41
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
23-04-2026
Poslední dividenda
13-03-2026

Profil

Biofarmaceutická společnost Gilead Sciences, Inc., objevuje, vyvíjí a komercializuje léčivé přípravky v oblastech nenaplněných léčebných potřeb ve Spojených státech, Evropě a na mezinárodní úrovni. Společnost poskytuje přípravky Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild a Atripla pro léčbu HIV/AIDS; Veklury, injekci pro intravenózní použití, pro léčbu koronavirové choroby 2019; a Epclusa, Harvoni, Vosevi, Vemlidy a Viread pro léčbu jaterních onemocnění. Nabízí také produkty Yescarta, Tecartus, Trodelvy a Zydelig pro léčbu pacientů s hematologií, onkologií a buněčnou terapií. Společnost dále poskytuje přípravek Letairis, perorální formu pro léčbu plicní arteriální hypertenze; přípravek Ranexa, perorální formu pro léčbu chronické anginy pectoris; a přípravek AmBisome, lipozomální formu pro léčbu závažných invazivních mykotických infekcí. Společnost Gilead Sciences, Inc. má dohody o spolupráci s Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; a Merck & Co, Inc. Společnost byla založena v roce 198 7 a má sídlo ve Foster City v Kalifornii.
Sektor
Healthcare
Odvětví
Drug Manufacturers - General
Počet zaměstnanců
17600
Založení
1992-01-22
Adresa
333 Lakeside Drive
CEO
Daniel P. O'Day

Podobné společnosti

$ 24.16
- $ 0.28
$ 321.61
+ $ 1.41
$ 50.17
+ $ 0.51
$ 46.75
+ $ 0.12
$ 86.23
- $ 0.05
$ 209.92
- $ 0.03

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues29.4429.4428.7527.1227.2827.3124.6922.4522.1326.1130.3932.6424.8911.209.708.397.95
Cost of Revenues5.653.926.256.505.666.604.574.684.854.374.264.013.792.862.472.121.87
Gross Profit23.7925.5222.5020.6221.6220.7020.1217.7717.2721.7426.1328.6321.108.347.236.266.08
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues7.937.777.086.677.577.556.956.697.127.05
Cost of Revenues1.041.571.501.541.581.571.541.551.561.57
Gross Profit6.886.205.585.135.995.975.415.135.565.49
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.000.000.006.924.985.365.049.115.023.735.103.012.852.121.761.231.07
Selling General & Admin Expenses0.000.000.006.095.675.255.154.384.063.883.403.432.981.701.461.241.04
Depreciation & Amortization2.070.002.772.693.062.051.481.871.431.291.161.101.050.340.280.300.27
Total Operating Expenses12.7913.7120.8413.0110.6510.6110.1913.499.077.618.506.445.843.823.222.472.12
Operating Income11.0011.821.667.617.337.417.034.298.2014.1217.6322.1915.274.524.013.793.96
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.000.000.000.000.000.000.000.001.451.46
Selling General & Admin Expenses0.000.000.000.000.000.000.000.001.601.32
Depreciation & Amortization0.000.690.690.700.690.690.690.690.690.68
Total Operating Expenses3.922.873.112.893.545.082.779.463.052.77
Operating Income2.963.332.472.242.450.892.64-4.322.512.62
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income0.260.000.280.000.000.000.000.000.000.000.000.000.000.000.000.070.06
Interest Expense1.031.020.980.940.941.000.981.001.081.120.960.690.410.310.360.210.11
Other Expense-1.21-2.02-0.97-0.75-1.520.87-5.360.870.680.520.430.150.00-0.01-0.04-0.14-0.05
IBT9.809.800.696.865.818.281.675.167.8013.5317.1021.6614.864.213.613.653.91
Income Tax Expense1.291.290.211.251.252.081.58-0.202.348.893.613.552.801.151.040.861.02
Net Income8.518.510.485.674.596.230.095.395.464.6313.5018.1112.103.072.592.802.90
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.000.090.070.090.090.050.040.110.250.23
Interest Expense0.260.260.250.260.250.240.240.250.250.23
Other Expense-0.890.31-0.05-0.59-0.290.07-0.59-0.160.04-0.31
IBT2.083.642.431.652.170.962.05-4.491.652.32
Income Tax Expense-0.110.590.470.330.39-0.300.44-0.320.240.15
Net Income2.183.051.961.321.781.251.61-4.171.432.18
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$4.54$3.66$4.96$0.07$4.24$4.20$3.54$10.08$12.37$7.95$2.01$1.71$1.81$1.70
EPS Diluted$0.00$0.00$0.00$4.50$3.64$4.93$0.07$4.22$4.17$3.51$9.94$11.91$7.35$1.81$1.64$1.78$1.66
Shares Outstanding1.241.241.251.251.261.261.261.271.301.311.341.461.521.531.511.551.71
Diluted Shares Outstanding1.251.261.261.261.261.261.261.281.311.321.361.521.651.691.581.581.75
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.15$1.75
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.14$1.73
Shares Outstanding1.241.241.251.251.251.251.251.251.251.25
Diluted Shares Outstanding1.251.251.261.261.261.251.251.251.261.26
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents2.779.996.095.415.346.0011.6317.947.598.2312.8510.032.111.809.880.91
Short Term Investments1.431.581.180.971.181.4112.7212.1517.923.671.760.100.020.060.021.19
Total Cash & ST Investments4.2011.577.267.637.837.9125.8431.5136.6932.3826.2111.732.572.589.902.10
Accounts Receivable4.664.424.664.784.494.893.583.333.854.515.854.642.101.751.951.62
Inventory2.031.711.792.822.733.012.070.810.801.591.961.392.061.741.391.20
Other Current Assets1.431.482.371.772.142.011.441.611.661.060.510.470.090.809.965.32
Total Current Assets12.3219.1716.0915.2315.0615.8231.4935.6541.3538.4834.0217.756.736.0813.318.14
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents7.335.147.939.995.042.774.726.095.715.70
Short Term Investments0.020.070.001.581.661.431.341.181.168.00
Total Cash & ST Investments7.355.217.9311.576.704.206.068.438.028.00
Accounts Receivable5.104.784.394.424.594.664.674.664.794.23
Inventory1.791.831.761.711.872.031.853.373.203.18
Other Current Assets3.652.902.831.481.631.431.462.372.661.76
Total Current Assets17.8714.7216.9019.1714.7812.3214.0416.4516.0115.41
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment5.355.415.325.485.124.974.504.013.302.872.281.671.171.100.770.70
Goodwill8.318.318.318.318.338.114.124.124.161.171.171.171.171.061.001.43
Intangible Assets22.8319.9526.4528.8933.4633.1313.7915.7417.108.9710.2511.0711.9011.742.071.43
Long-Term Investments0.710.001.161.251.310.501.491.4211.1820.4911.601.600.440.720.063.22
Other Long-Term Assets4.066.154.794.025.996.397.734.164.38-15.40-7.801.160.940.410.95-2.05
Total Long-Term Assets41.2639.8246.0447.9452.9052.5930.1428.0228.9418.5017.8216.9215.7715.164.003.45
Total Assets53.5859.0062.1363.1767.9568.4161.6363.6870.2856.9851.8434.6622.5021.2417.3011.59
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment5.505.465.425.415.395.355.325.325.575.54
Goodwill8.318.318.318.318.318.318.318.318.318.31
Intangible Assets17.9718.5719.3519.9520.5522.8323.4326.4527.1527.75
Long-Term Investments2.011.910.680.000.730.711.141.161.161.33
Other Long-Term Assets4.874.033.196.154.764.064.045.595.3210.43
Total Long-Term Assets40.6641.0139.5339.8239.7441.2642.2545.6746.3646.93
Total Assets58.5355.7256.4359.0054.5353.5856.2962.1362.3762.34
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable0.540.830.550.910.710.840.710.790.811.211.180.961.261.331.210.80
Short-Term Debt1.811.821.802.271.522.762.502.752.75-1.410.000.020.061.170.000.65
Other Current Liabilities7.708.537.728.069.397.806.557.0711.649.228.274.514.901.671.230.91
Current Liabilities10.7812.0011.2811.2411.6111.409.7610.6111.649.229.895.626.334.272.512.46
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable0.810.580.740.830.900.540.620.550.590.62
Short-Term Debt2.812.812.811.931.811.813.671.801.794.04
Other Current Liabilities8.687.808.807.607.477.177.537.727.486.70
Current Liabilities12.3011.1912.3412.0011.7210.7813.0211.2811.9513.96
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt21.5424.9023.1922.9625.1828.6522.0924.5730.8026.3521.2011.923.947.057.612.95
Capital Leases1.421.301.281.180.985.131.011.040.560.300.400.540.160.230.150.03
Def. Tax Liability0.910.721.592.674.360.000.000.000.000.400.320.050.080.130.140.15
Total Liabilities35.3839.7539.3841.9646.8950.1938.9842.1449.7837.6132.7318.8510.7511.6910.445.47
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt22.1422.1422.1525.3921.4421.5421.5323.7423.1921.21
Capital Leases0.000.000.001.301.401.421.400.550.921.35
Def. Tax Liability0.600.650.710.720.790.910.931.591.982.11
Total Liabilities37.0836.1337.3639.7536.1435.3838.8439.3840.1341.24
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Retained Earnings11.1711.5016.3015.6916.3214.3819.3919.0219.0118.1518.0012.736.113.701.781.18
Comprehensive Income0.090.130.030.000.08-0.060.090.080.170.280.090.30-0.12-0.050.060.03
Total Common Equity18.2819.3322.8321.2121.0618.2222.6521.5320.5019.3619.1115.8211.749.556.876.12
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.000.000.000.000.000.000.000.000.000.00
Retained Earnings12.8311.3310.9311.5011.0711.1710.6616.3016.0015.14
Comprehensive Income0.04-0.020.090.130.070.090.070.030.030.01
Total Common Equity21.5419.6819.1619.3318.4718.2817.5422.7522.2421.09
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt23.3526.7124.9925.2326.7031.4024.5927.3233.5426.350.000.020.068.227.613.59
Book Value18.2019.2522.7521.2121.0618.2222.6521.5320.5019.3619.1115.8211.749.556.876.12
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt-0.08-0.08-0.08-0.08-0.08-0.08-0.08-0.08-0.07-0.06
Book Value21.5419.6819.1619.3318.4718.2817.5422.7522.2421.09
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income1.038.510.485.614.576.200.095.365.464.6413.4918.1112.063.062.572.792.89
Depreciation & Amortization2.762.762.772.692.102.051.481.401.431.291.161.101.050.340.280.300.27
Stock-Based Compensation0.800.000.840.800.640.640.640.640.850.640.380.380.360.250.210.190.20
Change Working Capital-4.10-3.95-0.88-2.30-1.760.49-1.64-0.80-0.945.111.361.16-0.52-0.560.180.22-0.68
Change In Accounts Receivable-0.49-0.370.140.16-0.410.31-1.17-0.220.480.751.19-1.40-2.58-0.320.20-0.38-0.35
Change In Accounts Payable-0.08-0.130.29-0.350.23-0.120.08-0.06-0.04-0.430.050.23-0.29-0.100.120.430.00
Change In Inventories-0.50-1.04-0.43-0.84-0.310.01-0.20-0.10-0.31-0.25-0.49-0.860.14-0.34-0.35-0.20-0.16
Other Non-cash Items11.692.549.472.175.082.137.814.641.320.300.21-0.61-0.38-0.17-0.120.030.15
Cash from Operations7.470.000.008.019.0711.388.179.148.4011.9016.6720.3312.823.103.193.642.83
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income2.183.051.961.321.781.251.61-4.171.422.17
Depreciation & Amortization0.670.690.690.700.690.690.690.690.690.68
Stock-Based Compensation0.000.230.230.210.220.220.210.190.200.20
Change Working Capital-0.60-0.30-2.01-1.030.480.64-1.55-0.46-0.54-1.55
Change In Accounts Receivable0.18-0.33-0.290.080.070.16-0.03-0.070.22-0.61
Change In Accounts Payable-0.100.23-0.16-0.11-0.060.36-0.080.07-0.04-0.03
Change In Inventories-0.12-0.52-0.18-0.22-0.23-0.09-0.07-0.05-0.31-0.08
Other Non-cash Items1.20-0.220.140.770.172.080.526.690.780.32
Cash from Operations0.000.000.000.000.000.000.000.002.171.76
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-0.57-0.56-0.52-0.59-0.73-0.58-0.65-0.83-0.92-0.59-0.75-0.75-0.56-0.19-0.40-0.13-0.06
Acquisitions-4.55-1.07-4.84-1.15-1.80-1.40-25.740.830.35-10.430.360.000.02-0.38-10.75-0.59-0.09
Investments-1.76-4.07-0.74-2.37-1.94-3.90-20.77-32.23-10.58-23.31-25.98-17.24-2.13-0.26-1.27-5.13-5.50
Sales of Investment3.400.912.591.842.002.9132.7229.9225.8618.2614.745.510.860.570.579.443.72
Other Investing Activities-0.220.000.000.000.00-0.16-0.17-5.51-0.350.00-0.360.00-0.020.000.000.000.00
Cash from Investing-3.470.000.00-2.27-2.47-3.13-14.62-7.8214.36-16.07-11.99-12.48-1.82-0.25-11.853.59-1.94
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-0.21-0.15-0.11-0.10-0.15-0.14-0.13-0.11-0.22-0.12
Acquisitions-0.61-0.17-0.02-0.27-0.08-0.57-0.15-4.04-0.28-0.08
Investments-1.40-0.35-2.31-0.02-0.04-0.01-0.03-0.65-0.68-0.40
Sales of Investment0.360.240.310.000.000.000.002.590.450.36
Other Investing Activities0.000.000.000.000.000.000.000.00-0.230.01
Cash from Investing0.000.000.000.000.000.000.000.00-0.73-0.23
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-4.100.000.00-0.27-1.50-4.75-2.50-2.75-6.25-1.81-1.98-1.00-4.81-4.44-1.84-0.65-0.87
Debt Issued0.8526.711.720.030.040.049.310.020.039.0128.330.984.76-3.722.464.674.46
Issuance of Common Stock0.260.000.000.230.310.170.260.210.290.230.210.320.330.310.470.210.22
Repurchase of Common Stock-0.95-1.92-1.15-1.00-1.40-0.55-1.58-1.75-2.90-0.95-11.00-10.00-5.35-0.58-0.67-2.38-4.02
Dividends Paid-3.860.000.00-3.81-3.71-3.61-3.45-3.22-2.97-2.73-2.46-1.87-6.38-1.73-2.36-4.66-3.12
Other Financing Activities1.720.000.00-0.28-0.17-0.158.05-0.12-0.498.665.887.5913.183.904.969.256.45
Cash from Financing-6.930.000.00-5.13-6.47-8.880.77-7.63-12.323.39-9.35-4.96-3.03-2.540.561.76-1.34
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.000.000.000.000.000.000.000.000.00-0.27
Debt Issued24.94-0.01-0.01-2.374.07-0.10-1.840.21-0.92-0.42
Issuance of Common Stock0.000.000.000.000.000.000.000.000.030.08
Repurchase of Common Stock-0.23-0.44-0.53-0.73-0.35-0.30-0.10-0.40-0.15-0.30
Dividends Paid0.000.000.000.000.000.000.000.00-0.94-0.95
Other Financing Activities0.000.000.000.000.000.000.000.00-0.03-0.08
Cash from Financing0.000.000.000.000.000.000.000.00-1.10-1.52
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-2.93-2.433.910.670.07-0.66-5.63-6.3110.35-0.64-4.622.827.910.31-8.088.98-0.37
Closing Cash Balance2.777.569.996.095.415.346.0011.6317.947.598.2312.8510.032.111.809.880.91
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash0.232.19-2.78-2.074.952.27-1.95-1.370.380.00
Closing Cash Balance7.567.335.147.939.995.042.774.726.095.71
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow6.909.4610.317.428.3410.817.528.327.4811.3115.9219.5812.262.912.803.512.77
Real Free Cash Flow6.109.469.476.637.7110.176.887.686.6310.6715.5419.2011.902.662.593.312.57
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow3.123.960.721.652.834.171.202.111.951.63
Real Free Cash Flow3.123.730.501.442.613.950.991.931.751.43
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E20.247.586.1
P/S5.85578
P/B86582.9
P/FCF19.615.510581.1
Market cap$146.4$111.5
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %33.6 %0 %
Debt to Income293.1 %1153.3 %0 %
Debt to Free cash flow283.7 %30246.9 %0 %
Interest expense percentage9.3 %7.9 %7 %
Current ratio1.5 2.4 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE39.5 %35 %0 %
ROA14.5 %13.8 %0 %
CapEx to Revenue1.2 %2.3 %10.5 %
RaD to Revenue0 %18.5 %0 %
ROEM1,672,840.9 1906850.2

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin80.8 %79.2 %77.7 %
Operating margin37.4 %41 %29.4 %
Net margin28.9 %27.1 %22.3 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %4.5 %0 %
Dividend payout percentage0 %225.2 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding1,253.0 mil 1,411.2 mil
Employee count17.6 tis 6.2 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader